-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GGN2z7x4iUHgxQdS3VbIeWBxj3VyagCbmyveqGI5lNLncavRqs4Z/6vHbt4HwOXP N/obk1i2+XTlhffRDL/z4w== 0001104659-07-051597.txt : 20070702 0001104659-07-051597.hdr.sgml : 20070702 20070702114943 ACCESSION NUMBER: 0001104659-07-051597 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20070504 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070702 DATE AS OF CHANGE: 20070702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 3M CO CENTRAL INDEX KEY: 0000066740 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 410417775 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03285 FILM NUMBER: 07953656 BUSINESS ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-11W-02 CITY: ST PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 6517332204 MAIL ADDRESS: STREET 1: 3M CENTER STREET 2: BLDG. 220-11W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: MINNESOTA MINING & MANUFACTURING CO DATE OF NAME CHANGE: 19920703 8-K 1 a07-16241_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 4, 2007

3M COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

File No. 1-3285

 

41-0417775

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

3M Center, St. Paul, Minnesota

 

55144-1000

(Address of Principal Executive Offices)

 

(Zip Code)

 

(651) 733-1110

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 




Item 8.01. Other Events.

Attached as Exhibit 100 to this report are the following financial statements from 3M Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2007, filed with the Securities and Exchange Commission on May 4, 2007, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statement of Income for the three months ended March 31, 2007 and 2006, (ii) the Consolidated Balance Sheet at March 31, 2007 and December 31, 2006 and (iii) the Consolidated Statement of Cash Flows for the three months ended March 31, 2007 and 2006. Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial and other information contained in the XBRL documents is unaudited and that these are not the official publicly filed financial statements of 3M Company. The purpose of submitting these XBRL formatted documents is to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed to be “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit Number

 

Description

 

 

 

100

 

The following financial statements from 3M Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2007, filed on May 4, 2007, formatted in XBRL: (i) the Consolidated Statement of Income for the three months ended March 31, 2007 and 2006, (ii) the Consolidated Balance Sheet at March 31, 2007 and December 31, 2006 and (iii) the Consolidated Statements of Cash Flows for the three months ended March 31, 2007 and 2006.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

3M COMPANY

 

 

 

 

 

By:

/s/ Gregg M. Larson

 

 

 

 Gregg M. Larson,

 

 

 Deputy General Counsel and Secretary

 

 

 

 

 

 

Dated: July 2, 2007

 

 

 

2




EXHIBIT INDEX

Exhibit Number

 

Description

 

 

 

100

 

The following financial statements from 3M Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2007, filed on May 4, 2007, formatted in XBRL: (i) the Consolidated Statement of Income for the three months ended March 31, 2007 and 2006, (ii) the Consolidated Balance Sheet at March 31, 2007 and December 31, 2006 and (iii) the Consolidated Statements of Cash Flows for the three months ended March 31, 2007 and 2006.

 

3



EX-100.INS 2 mmm-20070331.xml EX-100.INS mmm2006-01-012006-03-31mmm 2007-01-012007-03-31mmm2005-12-31mmm2006-03-31mmm2006-12-31mmm2007-03-31iso4217:USD< /xbrli:measure>xbrli:shares5595000000220000008000000-14000000135500000044300000013000000899000000272100000011830000003220000000422600000013690000007544000001.197686000001.170.46593700000030220000001281000000319000000-786000000383600000021010000003800000028000000-1000000020910000007080000001500000013680000007293000001.887413000001.850.4816970000005890000003444000000128500000084200000058700000012820000009726000000526000000282000000172710000001128000000059910000004140000000427000000936000000227390000002831000000144100000054300000091500000017740000007504000000177100000034100000001268500000090000000.019440330562527000000189050000009521000000223828365117000000-1749000000100540000002273900000027140000001447000000471000000310200000012350000007950000005710000002601000000132500000089460000001660000003140000001701700000011110000000590700000040820000003950000007760000002129400000025060000001402000000520000000113400000017610000007323000000104700000029650000001133500000090000000.019440330562484000000179330000008456000000209670254138000000-1873000000995900000021294000000254000000-610000005700000033000000-222000000-7000000-319000000-1070000004900000035300000075000000-107000000580000000246000000-650000009900000025000000-5000000-7000000-239000000-20000000073000000-61000000-18000000-129000000618000000-19000000016000000-22000000-397000000500000000-588000000417000000-1480000000-251000000100000000-34700000007000000-6000000-228000000-16000000038000000-3040000004000000-55000000-328500000027410000009500000081700000013000000-448000000-560000001565000000-116400000098000000-350000000-100000007000000-6000000-364000000210000002500000001072000000912000000711000000708000000Activit ies that represent increases in cash flow are shown as a positive number, while activities that represent decreases in cash flow are shown as a negative number. EX-100.SCH 3 mmm-20070331.xsd EX-100.SCH EX-100.CAL 4 mmm-20070331_cal.xml EX-100.CAL EX-100.LAB 5 mmm-20070331_lab.xml EX-100.LAB TotalOther - NetCash Dividends Paid Per Common Share< link:label xlink:type="resource" xlink:label="label_ResearchDevelopmentRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchDevelopmentRelatedExpenses" xml:lang="en" id="label_ResearchDevelopmentRelatedExpenses">Research, Development and Related ExpensesGain on Sale of Pharmaceuticals BusinessInventories - Raw Materials and SuppliesPrepaid Pension and Postretirement BenefitsShort-term Borrowings and Current Portion of Long-term DebtCompany Pension and Postretirement ContributionsCompany Pension and Postretirement ExpenseStock Based Compensation ExpenseExcess Tax Benefits Stock Based CompensationProduct Other Insurance Receivables and ClaimsPuchases of Property, Plant and Equipment (PP&E)Purchases of Marketable Securities and InvestmentsProceeds from Sale of Marketable Securities and InvestmentsProceeds from Sale of Pharmace uticals BusinessChange in Short-term Debt, NetExcess Tax Benefits from Stock-based Compensation EX-100.PRE 6 mmm-20070331_pre.xml EX-100.PRE
-----END PRIVACY-ENHANCED MESSAGE-----